Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (351-360 of 652) with videos related to

Pageof 66
Sort By:
Science Advances|June 18, 2020
Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse modelTimothy S Jayme, Gabriella Leung, Arthur Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on BiologicsKenneth Ernest-Suarez, Luis E Murguía-Favela, Cora Constantinescu, et al.
Journal of Leukocyte Biology|June 29, 2026
High-dimensional single-cell mass cytometry analysis of IL-4 treated human macrophages reveals heterogeneity and a CD206high anticolitic subsetBlanca E Callejas, Jared Schlechte, James A Sousa, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis|January 11, 2015
Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel diseaseYvette P Y Leung, Gilaad G Kaplan, Stephanie Coward, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseChristopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
La Clinica Terapeutica|March 4, 2010
Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasisS Coaccioli, A Panaccione, R Biondi, et al.
Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
The American Journal of Gastroenterology|June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid RegistryGeert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Pageof 66

Showing results (351-360 of 652) with videos related to

Sort By:
Pageof 66
Science Advances|June 18, 2020
Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse modelTimothy S Jayme, Gabriella Leung, Arthur Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 1, 2024
Live Rotavirus Vaccination Appears Low-risk in Infants Born to Mothers With Inflammatory Bowel Disease on BiologicsKenneth Ernest-Suarez, Luis E Murguía-Favela, Cora Constantinescu, et al.
Journal of Leukocyte Biology|June 29, 2026
High-dimensional single-cell mass cytometry analysis of IL-4 treated human macrophages reveals heterogeneity and a CD206high anticolitic subsetBlanca E Callejas, Jared Schlechte, James A Sousa, et al.
Gastroenterology|January 24, 2007
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trialJean-Frédéric Colombel, William J Sandborn, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis|January 11, 2015
Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel diseaseYvette P Y Leung, Gilaad G Kaplan, Stephanie Coward, et al.
Alimentary Pharmacology & Therapeutics|May 24, 2019
Systematic review with meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel diseaseChristopher Ma, Jeffrey K Lee, Anish R Mitra, et al.
La Clinica Terapeutica|March 4, 2010
Evaluation of oxidative stress in rheumatoid and psoriatic arthritis and psoriasisS Coaccioli, A Panaccione, R Biondi, et al.
Journal of Crohn'S & Colitis|July 20, 2024
Re-evaluating Methods for Assessing Differences in Response in Ileal vs Colonic Crohn's Disease: A Post-hoc Analysis of the FITZROY TrialChristopher Ma, Brian G Feagan, Zhongya Wang, et al.
Journal of Crohn'S & Colitis|December 9, 2023
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 StudiesJean-Frederic Colombel, Stefan Schreiber, Geert D'Haens, et al.
The American Journal of Gastroenterology|June 6, 2018
Lymphoma Risk and Overall Safety Profile of Adalimumab in Patients With Crohn's Disease With up to 6 Years of Follow-Up in the Pyramid RegistryGeert DʼHaens, Walter Reinisch, Remo Panaccione, et al.
Pageof 66